One of the most important problems for patients
|
|
- Herbert Tate
- 5 years ago
- Views:
Transcription
1 Selection of Donors and Recipients for Living Donor Liver Transplantation Key Points 1. Living donor liver transplantation (LDLT) is increasingly used for adults with end-stage liver disease. 2. Standards for acceptable rates of donor morbidity, and even mortality, must be evaluated in the context of recipient risk of dying while on the waiting list and outcome after transplantation. 3. Use of our current criteria in Colorado for selection of donors and recipients indicated that 15% of recipients could undergo LDLT. (Liver Transpl 2000;6:S52-S58.) One of the most important problems for patients listed for liver transplantation is the lack of sufficient donor organs. Over the past 10 years, the number of patients listed for liver transplantation has increased more than 15-fold, with more than 15,000 patients currently listed in the United States. 1 However, the number of available donor livers has increased only 3-fold in the past 10 years. Because of the worsening shortage of donor livers, the median waiting time for US liver transplants has increased from 34 days in 1988 to 496 days in As a result, the number of patients dying while on the liver transplant list has increased from 196 in 1988 to 1,317 in With more patients dying awaiting a donor organ, there is a growing incentive to develop novel strategies to increase the availability of donor livers. One possible solution is the use of living donor orthotopic liver transplantation (LDLT). In this procedure, the native liver of the recipient is removed and replaced with a portion of the liver from a living donor. Although LDLT using the lateral segment of the left hepatic lobe is a common therapy for children in the United States, the small size of the graft has limited its use in adults. LDLT in adults using the right hepatic lobe provides a larger graft and overcomes concerns about small graft size. The current critical shortage of adult donor organs has stimulated several US From the Division of Gastroenterology and Hepatology, University of Colorado Health Sciences Center, Denver, CO. Address correspondence to, MD, Division of Gastroenterology and Hepatology, University of Colorado Health Sciences Center, 4200 E 9th Ave, B-158, Denver, CO Telephone: ; FAX: ; james.trotter@uchsc.edu Copyright 2000 by the American Association for the Study of Liver Diseases /00/ $3.00/0 doi: /jlts transplant centers to use the right hepatic lobe for LDLT in selected adult recipients. 2-5 The initial success of this surgery has led to an interest in LDLT at an increasing number of liver transplant centers in the United States. This article outlines our program s strategy toward the appropriate selection of donors and recipients for LDLT. Potential Advantages of LDLT The greatest of several potential benefits for the recipient with LDLT is the possible reduction in waiting time for transplantation. A shorter waiting time might mean that more patients could undergo transplantation before they die, thus reducing the number of deaths on the waiting list. In addition, a reduced waiting time may decrease the risk for clinical deterioration before transplantation, which could improve the success of the transplant. A recent analysis of adult living donor liver transplant recipients from the United Network for Organ Sharing (UNOS) showed a 40% reduction in waiting time for adult living donor liver transplant recipients between 1998 and 2000 compared with cadaveric transplant recipients over the same time. 1 Another potential advantage of LDLT is that surgery is often elective, usually not performed on an urgent or emergent basis. As a result, the evaluation for LDLT can be accomplished in a few days, after which surgery may be scheduled. Even more urgent evaluations have been performed within hours in the setting of fulminant hepatic failure. 6 Consequently, the medical conditions of the recipient and donor can be stabilized or improved before surgery, thus increasing the likelihood of a successful transplant. A third advantage is the quality of the donor organ. The liver from a living donor may be of better quality because it is harvested from a healthy person. The potential donor may also undergo extensive testing to rule out medical illness in the donor and abnormalities of the donor organ. Conversely, by definition, a cadaveric donor organ is harvested from a patient who has recently died. The donor frequently is maintained for days on mechanical ventilation and vasopressor therapy, with a critical illness that may compromise the function of the cadaveric liver. The next advantage is that the donor liver experi- S52 Liver Transplantation, Vol 6, No 6, Suppl 2 (November), 2000: pp S52-S58
2 Donor and Recipient Selection for LDLT S53 ences minimal cold ischemic time because implantation occurs immediately after harvesting from the donor. From this standpoint, the liver from a living donor may be superior compared with the cadaveric donor. Finally, the use of a live donor adds another liver to the donor pool, allowing a cadaveric liver to go to another recipient. This could potentially shorten the waiting time and improve survival for recipients of cadaveric donor livers. Since the inception of the LDLT program at our center, the median waiting time for cadaveric UNOS status 2B recipients has decreased 27%, whereas the median waiting times for similar patients in the United States has increased 11% over the same period. 7 Potential Disadvantages of LDLT Even with the recent widespread application of LDLT in the past 2 years, only a fraction of all adult liver transplantations performed in the United States use living donors. Between January 1998 and June 2000, UNOS recorded only 213 adult living donor liver transplant recipients, whereas more than 10,000 cadaveric transplantations were performed during the same period. 1 Because a relatively small number of adult LDLTs have been performed, the full extent of the risks to the recipient and donor are not completely known. In addition, there are no long-term follow-up data for recipients or donors of this procedure because adult-to-adult right hepatic lobe LDLT has been performed for less than 5 years. The most important determinant in donor and recipient outcome is the experience and skill of the surgical team. Therefore, LDLT should only be performed in transplant centers in which the surgeons are vastly experienced in liver transplantation and major liver surgery. The ultimate impact of LDLT as an accepted treatment modality for patients with end-stage liver disease will depend largely on the morbidity and mortality rate of the donor right hepatectomy, as well as recipient outcome. Over the past year, several physicians have raised concerns regarding the safety and ethics of LDLT However, before a rational debate about LDLT can occur, there must be an accurate, comprehensive assessment of all complications for living liver transplant donors and recipients. Toward this end, the transplant community has recently launched an initiative through the American Society of Transplant Surgeons to generate a national database to record the outcomes for all donors and recipients of living donor liver transplants. For the recipient, the greatest risks are identical to those of conventional liver transplantation, i.e., surgical complications, infection, and rejection. To date, patient and graft survival for living donor liver transplant recipients has not been different from cadaveric recipients. In the survey of North American transplant centers by Renz and Busuttil, 12 survival for living donor liver transplant recipients was 180 of 208 patients (87%), similar to that of cadaveric transplantation. 12 LDLT patient and graft survival rates at the University of Colorado were 23 of 25 patients (92%) and 21 of 25 grafts (84%). 3,13 At the Medical College of Virginia, patient survival was 35 of 40 patients (88%), and graft survival was 34 of 40 grafts (85%). 3 Despite these favorable outcomes, several risks are inherent to LDLT. Although hepatic regeneration in the transplanted graft occurs very quickly, the living donor liver transplant recipient usually receives a smaller hepatic mass compared with a cadaveric transplant and therefore does not have as much hepatic function or reserve until the transplanted lobe regenerates to full size. However, rarely has this caused clinical problems. Marcos et al 14 reported the increase in mean liver mass in living donor liver transplant recipients 7, 14, 30, and 60 days posttransplantation. Recipients showed an increase in liver graft size of 87% at 7 days posttransplantation, from 862 ml at the time of donation to 1,614 ml at day 7. Remarkably, the graft reached 94% of its final regenerated volume by postoperative day 7. The transplant recipient may also incur a greater chance for biliary complications; the most common is a bile leak from the cut parenchymal surface of the graft. However, most are treatable with either a surgical or percutaneous approach. Biliary complications in LDLT have been recorded in a recent survey by Renz and Busuttil. 12 Of 208 reported LDLTs, 37 patients (18%) developed biliary complications, including 7 strictures, 4 anastomotic leaks, and 26 parenchymal leaks. The number of biliary complications at the University of Colorado 13 was 8 of 25 LDLTs (32%), and at the Medical College of Virginia, 7 of 40 LDLTs (18%). 3 Most donors undergo successful right hepatectomy without complications. In the survey by Renz and Busuttil, donor complications in 208 procedures (8%) were reported, including 6 biliary complications, 3 pressure ulcers, and 1 each of pulmonary embolus, incisional hernia, pneumonia, bowel obstruction, aborted donor, phlebitis, atelectasis, and death. Fan et al 15 published their experience with donor complications in 22 right hepatic lobe donor graft surgeries. Five patients (23%) developed complications, including wound infection, biliary stricture, cholestasis, peroneal nerve palsy, and small-bowel obstruction. All donors completely recovered and have returned to
3 S54 work. At our institution, 6 of 25 donors (24%) developed the following complications: bile leak (2 donors), incisional hernia (1 donor), transient neuropraxia (1 donor), reoperation for drainage tube retrieval (1 donor), and transient encephalopathy (1 donor). 16 All donors have fully recovered and returned to their predonation occupations and activities. At the Medical College of Virginia, 7 of 40 donors (18%) experienced reported complications, including intraoperative pressure ulcers (3 donors), phlebitis (1 donor), prolonged ileus (1 donor), and atelectasis (2 donors). 3 The donor is left with approximately half or less of their hepatic mass immediately after hepatectomy; however, rarely is there clinical evidence of hepatic insufficiency other than a prolonged prothrombin time, elevated serum aminotransferase levels, and increased bilirubin level, which normalize after 1 week. 4 The greatest concern for donor safety is the risk for donor death. As noted, 1 death was recorded in 208 donor surgeries (0.5%) in the survey by Renz and Busuttil. 12 Selection of Recipients The initial evaluation for living donor liver transplant recipients is identical to that for conventional liver transplantation. All recipients considered for LDLT must qualify for conventional transplantation because retransplantation immediately after LDLT would require the use of a cadaveric donor. The selection of appropriate recipients for living donor liver transplants is an evolving process and differs among centers. LDLT has been performed in patients with UNOS status 1, 2A, 2B, and 3. In patients with acute liver failure (UNOS status 1), progression to death occurs over the course of a few days or weeks. In this setting, the evaluation of potential donors must be performed within a few hours or days, depending on the condition of the recipient. LDLT has been performed successfully in this setting. However, less than 5% of all liver transplantations are performed for patients with fulminant hepatic failure. Although the use of LDLT in this setting is dramatic, the relative impact of LDLT is limited because of the small fraction of liver transplantations performed for fulminant hepatic failure. As experience has grown, some transplant centers performing LDLT have found an increased incidence of complications and mortality for status 2A recipients compared with status 2B or 3 patients. 3 As a result, these critically ill patients may be better suited for expedited cadaveric transplantation instead of LDLT. There is currently no consensus about the selection of status 2B and 3 patients for LDLT. At our center, we believe LDLT should be offered primarily to status 2B patients. These patients are at the greatest risk for dying before a cadaveric donor organ becomes available. Consequently, the risk undertaken by the donor is balanced by the risk for recipient death without LDLT. In addition, 1-year survival for status 3 patients is not improved by transplantation. Other centers believe that the selection criteria for LDLT should be routinely extended to include status 3 patients. 3 They argue that less sick patients have the best chance for survival after transplantation. Furthermore, transplantation of status 3 patients may prevent future clinical deterioration and cadaveric transplantation. Patients with hepatocellular carcinoma (HCC), the most common malignancy in liver transplant recipients, pose a special problem. Once HCC is diagnosed in a potential liver transplant recipient, the patient may develop progressive malignant disease to the point that liver transplantation is contraindicated (tumor size 5 cm, 3 hepatic tumors, or metastatic disease). Although UNOS has recently changed its guidelines to increase the priority of patients with HCC, many patients still do not survive long enough to undergo transplantation. The advantage of LDLT in the setting of HCC is that the transplantation could be performed before the malignancy spreads. Therefore, patients with HCC with limited tumor burden (tumor size 5 cm, 3 tumors, and no evidence of malignant disease) may be considered for LDLT. LDLT may be the best treatment option for an increasing number of patients with cirrhosis with small hepatomas. The current relative contraindications for living donor liver transplant recipients vary among centers. At our center, we have excluded some patients for consideration for LDLT. Although all these patients were deemed suitable for a cadaveric transplant, they were rejected for LDLT because of a comorbid condition(s) that could jeopardize the success of the LDLT. These included advanced age, significant medical comorbid conditions, obesity, or patients with marginal psychosocial function. Of 100 potential living donor liver transplant recipients evaluated at our center between 1997 and 1999 (Fig. 1), 33 patients (33%) were rejected for the following recipient issues: medical comorbidity (15 patients), high-risk psychosocial (8 patients), obesity (7 patients), and retransplantation (3 patients). 17 Eighteen more patients (18%) were not considered for LDLT for the following reasons: unable to gain financial approval for LDLT (6 patients), refused LDLT evaluation (4 patients), and imminent cadaveric transplantation (8 patients).
4 Donor and Recipient Selection for LDLT S55 Figure 1. Outcome of 100 potential recipients evaluated for LDLT. Only 25 of the remaining 49 patients (50%) were able to identify a suitable donor for evaluation. The reasons patients did not have donors were often multifactorial, including no children, spouse, family member, or friend aged between 18 and 60 years; estrangement from family and/or friends; incompatible blood type; and obvious contraindication in the potential donor (active drug abuse, known severe medical problem, or massive obesity). With greater experience, the recipient selection criteria for LDLT may be broadened to include patients with medical comorbidities. However, in our experience, the majority of potential living donor liver transplant recipients listed for cadaveric transplants are unable to undergo LDLT because of medical comorbidities or the inability to identify a donor for evaluation. These factors may limit the widespread application of LDLT. Selection of Donors The potential living liver transplant donor must be in excellent medical and psychological condition. The specific tests and sequence of testing vary among centers. At our institution, we have 3 phases of donor evaluation (Table 1). First, potential recipients are identified, and financial clearance is obtained from the recipient s insurance carrier. The recipient may then accept volunteer potential donors with an identical or compatible blood type. The way in which potential donors are recruited for evaluation is important. The donor s decision to donate should be entirely voluntary and without direct or implied coercion of the donor by the recipient or transplant team. However, potential donors need to be aware that LDLT is a viable procedure for selected patients listed for liver transplantation. At our program as part of the evaluation for conventional transplantation, we make all potential conventional liver transplant recipients aware of the possibility of LDLT. This issue is discussed with them, and they are given appropriate literature regarding this procedure. If a potential donor is interested in pursuing LDLT, he or she must then voluntarily contact the transplant center. Potential donors are initially screened by an experienced hepatology nurse to determine obvious contraindications for donation. The following information is obtained from the potential donor: blood type; age; height; weight; brief medical, surgical, and psychiatric history; current medications; current smoking status; and nature of the relationship with the recipient. Screening laboratory tests are obtained (serum electrolyte levels, complete cell count, liver function tests, hepatitis C antibody, hepatitis B surface antigen, and hepatitis B core antibody). The results of the initial screening tests are then reviewed by the transplant team to determine whether further evaluation is warranted. Potential donors who pass this initial screening process are then offered complete donor evaluation. The second phase of evaluation determines whether the potential donor is medically, surgically, and psychologically fit to donate. The initial medical evaluation of the potential donor is performed after the potential donor has called to schedule an appointment. This evaluation should be performed by a transplant hepatologist so that the risks and benefits of donation and transplantation may be fully explained to the donor. During this evaluation, a complete medical history and physical examination are performed, as well as an electrocardiogram, chest radiograph, and the blood tests listed in Table 1. If potential donor is found suitable after this phase of evaluation, the patient is scheduled for surgical, anesthesia, psychosocial, and psychiatric evaluations and abdominal magnetic resonance imaging. Some potential donors require a third phase of evaluation, which includes tests to follow up potential abnormalities discovered during routine evaluation: endoscopic retrograde cholangiopancreatography, angiogram, liver biopsy, etc. At our center, we perform a liver biopsy only if there is concern about the donor s liver. The potential recipient and donor are then presented to the Transplant Selection Committee to determine ultimate suitability for LDLT. If both donor and recipient
5 S56 Table 1. Evaluation Phases for LDLT Phase 1 Recipient 1. UNOS status 1, 2A, 2B, or, at some centers, 3 2. Financial clearance for LDLT 3. Absence of significant contraindication (morbid obesity [recipient weight 130% of ideal body weight]; severe medical problem compromising outcome [pulmonary hypertension, previous CABG, etc]) 4. Psychosocially stable 5. Age 65 yr Donor 1. Age 18 and 60 yr 2. Identical or compatible blood type with recipient 3. Absence of previous significant abdominal surgery 4. Absence of major medical problems (diabetes; severe or uncontrolled hypertension; hepatic, cardiac, renal, or pulmonary disease; or active infection) 5. Demonstrable, significant, long-term relationship with recipient 6. Blood type; normal liver function test results; serum electrolyte levels; complete blood count with differential cell count; negative hepatitis B surface antigen, hepatitis B core antibody, and hepatitis C antibody 7. Absence of alcohol or illicit substance abuse Phase 2 1. Complete medical history and physical examination of potential donor 2. Laboratory tests (serum ferritin, iron, transferrin, ceruloplasmin, alpha 1 -antitrypsin level and phenotype; rapid plasma reagin, thyroid-stimulating hormone, cytomegalovirus antibody [IgG], Epstein-Barr virus antibody [IgG, IgM], antinuclear antibody, human immunodeficiency antibody), toxicology/substance abuse screen, urinalysis, blood oxygen saturation 3. Chest radiograph 4. Electrocardiogram 5. Formal surgical evaluation of donor 6. Anesthesia preoperative evaluation 7. Magnetic resonance imaging of the liver, biliary system, and hepatic vasculature Phase 3 Other tests or consultations to clarify potential problems uncovered during evaluation (endoscopic retrograde cholangiopancreatography, hepatic angiogram, liver biopsy, echocardiogram, stress echocardiogram, etc) Abbreviations: CABG, coronary artery bypass grafting; IgG, immunoglobulin G. are considered appropriate for LDLT after this evaluation, the transplantation is scheduled, usually within a few weeks of the evaluation. At our center, 15 of 25 identified donors (60%) who were evaluated ultimately were approved for donation. 17 The psychological and social issues related to LDLT donation are particularly relevant. The most important consideration is that the decision to donate must be entirely voluntary. At our institution, all potential donors are evaluated by a social worker and psychiatrist, whose primary goal is to ensure that the donation is voluntary. In addition, it is important to discover psychiatric and/or social problems in the potential donor that could influence their decision to donate or their postoperative course. The social worker and psychiatrist who perform this evaluation should be members of the transplant team and must be experienced in the assessment of liver transplant recipients so they can assess the patient in the context of the particular psychosocial demands of liver transplantation. Although most donors are first-degree relatives of the recipient, this is not a requirement. The potential donor must have a demonstrable, long-term, significant relationship with the recipient. Potential donors include spouses, first-degree relatives (parents or children), second-degree relatives (e.g., cousins, grandchildren, or grandparents), long-term friends, or steprelatives. Becoming a living organ donor may have both positive and negative psychosocial effects on the donor. Although the donor may gain psychological benefit from helping the recipient, potential negative psychosocial aspects of donation must be considered during donor evaluation. These include indirect costs of dona-
6 Donor and Recipient Selection for LDLT S57 tion (transportation to the transplant center for medical evaluation and care, lodging, and lost wages), stress on the donor and donor family, change in body image, and inability to work for at least 4 to 8 weeks after donation. The recipient s insurance carrier pays for all medical expenses related to the donor surgery for the donor. Currently, almost all third-party payers approve LDLT. However, in most cases, the process to gain approval for LDLT is separate from conventional transplantation. Insurance carriers often require data justifying the efficacy of this new procedure before approving the transplantation. This often requires significant time and effort on the part of the financial coordinator of the liver transplant team. The time to obtain financial approval for LDLT can take up to several months and may add to the waiting time on the list for the recipient. However, if LDLT becomes a more routine procedure, the financial approval process will likely occur more quickly. Many insurers already have a policy of comprehensive approval for conventional transplantation or LDLT, whichever surgery is indicated for the recipient. The cost of LDLT compared with conventional transplantation is unknown. However, preliminary data from our center and the Medical College of Virginia have shown that the cost of organ acquisition and LDLT is similar to cadaveric transplantation. 18,19 A comprehensive cost comparison between these 2 procedures will be reported when more LDLTs have been performed. Potential Impact of LDLT on Liver Transplantation Based on the successful preliminary results of adult LDLT at a few centers, there has been rapid acceptance and great excitement about the potential widespread application of this procedure. The impact of adult LDLT on liver transplantation will depend largely on the success and safety of donor and recipient surgery, as well as the proportion of cadaveric recipients deemed suitable for LDLT. For widespread acceptance of adult LDLT, graft and patient survival must be similar to those of cadaveric transplantation. In addition, the morbidity and mortality of right hepatic lobe donors must be minimized. It is our opinion that the most appropriate recipients for adult living donor liver transplants are patients with decompensated advanced liver disease (Child-Turcotte-Pugh score 10) or acute hepatic failure. Recipients should be without significant comorbidities that could compromise patient and graft survival. Using our current selection criteria, only approximately 5% of the patients listed for cadaveric transplants are ultimately able to undergo LDLT (Fig. Figure 2. Potential impact of LDLT on liver transplantation. 2). However, with greater experience, the indications for living donor liver transplant recipient selection may broaden to include a greater proportion of patients currently listed for cadaveric transplantation. There are many areas for future investigation in LDLT. The most important issue is a comprehensive analysis of the complications of living liver transplant donors and recipients. In addition, the impact of LDLT on waiting list mortality needs to be measured. A consensus regarding the selection of recipients based on severity of illness (UNOS status 2a v 2B v 3) needs to be developed based on outcome data for these patients. A comprehensive comparison of the expense of LDLT versus cadaveric transplantation should be performed. Such an analysis should compare the sum of pretransplantation, transplantation, and posttransplantation care. LDLT may reduce the expense of pretransplantation care by shortening the waiting time before transplantation. LDLT has rapidly emerged as a viable treatment option for selected patients listed for cadaveric
7 S58 transplantation. The continued careful application of LDLT in adults could help partially alleviate the current organ shortage and reduce the number of patients dying while awaiting cadaveric liver transplantation. References 1. United Network for Organ Sharing, Scientific Data Registry, Data, Marcos A. Right lobe living donor liver transplantation: A review. Liver Transpl 2000;6: Marcos A, Ham JM, Fisher RA, Olzinski AT, Posner MP. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 2000;6: Marcos A, Fisher RA, Ham JM, et al. Right lobe living donor liver transplantation. Transplantation 1999;68: Wachs ME, Bak TE, Karrer FM, et al. Adult living donor liver transplantation using a right hepatic lobe. Transplantation 1998; 66: Bak T, Everson G, Wachs M, et al. Living-donor liver transplantation for adults with fulminant hepatic failure (FHF): An underutilized resource [abstract]? Liver Transpl Surg 1999;5:C Trotter JF, Wachs M, Bak T, Trouillot T, Everson GT, Kam I. The effect of living donor liver transplantation on the waiting time of cadaveric UNOS status 2B patients at one center [abstract]. Hepatology 2000 (in press). 8. Lee KH, Tan KC. Whither living donor liver transplantation? Liver Transpl 2000;6: Strong RW. Whither living donor liver transplantation? Liver Transpl Surg 1999;5: Fan ST. Donor safety in living donor liver transplantation. Liver Transpl 2000;6: Hirano I, Blei AT. Deaths after living related liver transplantation. Liver Transpl 2000;6: Renz J, Busuttil RW. Results of living donor liver transplantation: Survey of North American liver transplant centers. New Engl J Med 2000 (submitted). 13. Wachs M, Bak T, Trotter JF, et al. Right hepatic lobe living donor liver transplantation: Results of 25 cases [abstract]. Hepatology 2000 (submitted). 14. Marcos A, Fisher RA, Ham JM, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69: Fan ST, Lo CM, Liu CL, Yong BH, Chan JK, Ng IO. Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg 2000;135: Bak T, Wachs M, Trotter J, et al. Adult donors of right hepatic lobes for living donor liver transplantation: Results of first 16 patients [abstract]. Transplantation 2000;69:S175A. 17. Trotter JF, Wachs M, Trouillot T, Steinberg T, Bak T, Everson GT, Kam I. Evaluation of 100 patients for living donor liver transplantation. Liver Transpl 2000;6: Ham JM, Marcos A, Fisher RA, et al. Is living donor liver transplant cost-effective [abstract]? Transplantation 2000;69:S175A. 19. Trotter JF, Wachs M, Trouillot T, et al. A comparison of charges for organ acquisition: Cadaveric vs adult living donor liver transplantation [abstract]. Transplantation 2000;69:S175A.
The New England Journal of Medicine. Review Article 16,000 14,000 12,000. No. of Patients 10,000 8,000 6,000 4,000 2,000
Review Article Medical Progress ADULT-TO-ADULT TRANSPLANTATION OF THE RIGHT HEPATIC LOBE FROM A LIVING DONOR JAMES F. TROTTER, M.D., MICHAEL WACHS, M.D., GREGORY T. EVERSON, M.D., AND IGAL KAM, M.D. TRANSPLANTATION
More informationLiving Donor Liver Transplantation NATCO Introductory Course
Living Donor Liver Transplantation NATCO Introductory Course Patricia Harren, RN, ANP, MSN, PNP, CCTC New York Presbyterian Medical Center Center for Liver Disease & Transplant New York, NY Living Donor
More informationAs the shortage of donor organs for liver transplantation
RAPID COMMUNICATION Right Hepatic Lobe Donation for Living Donor Liver Transplantation: Impact on Donor Quality of Life James F. Trotter, * Michael Talamantes, Mary McClure, Michael Wachs, Thomas Bak,
More informationInformed Consent for Liver Transplant Patients
Informed Consent for Liver Transplant Patients Evaluation Process You will be evaluated with consultations, lab tests and various procedures to determine the medical appropriateness of liver transplant.
More informationInformation for patients (and their families) waiting for liver transplantation
Information for patients (and their families) waiting for liver transplantation Waiting list? What is liver transplant? Postoperative conditions? Ver.: 5/2017 1 What is a liver transplant? Liver transplantation
More informationYour Health Matters. What You Need to Know about Adult Liver Transplantation. Access our patient education library online at
Access our patient education library online at www.ucsfhealth.org Your Health Matters What You Need to Know about Adult Liver Transplantation Table of Contents 1. Introduction 2. The Preliminary Process
More informationEvaluation Process for Liver Transplant Candidates
Evaluation Process for Liver Transplant Candidates 2 Objectives Identify components of the liver transplant referral to evaluation Describe the role of the liver transplant coordinator Describe selection
More informationOverall Goals and Objectives for Transplant Hepatology EPAs:
Overall Goals and Objectives for Transplant Hepatology EPAs: 1. DIAGNOSTIC LIST During the one-year Advanced Pediatric Transplant Hepatology Program, fellows are expected to develop comprehensive skills
More informationOntario s Referral and Listing Criteria for Adult Kidney Transplantation
Ontario s Referral and Listing Criteria for Adult Kidney Transplantation Version 3.0 Trillium Gift of Life Network Adult Kidney Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The
More informationLive Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease
Live Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease Abhi Humar, MD Clinical Director, Thomas E. Starzl Transplantation Institute 1 PITTSBURGH THE BIRTHPLACE OF LIVER TRANSPLANTATION
More informationIowa Methodist Medical Center Transplant Center. Informed Consent for Kidney Transplant Recipient
Iowa Methodist Transplant Center Iowa Methodist Medical Center Transplant Center 1215 Pleasant Street, Suite 506 Des Moines, IA 50309 515-241-4044 Phone 515-241-4100 Fax Iowa Methodist Medical Center Transplant
More informationA Survey of Liver Transplantation from Living Adult Donors in the United States
The new england journal of medicine special article A Survey of Liver Transplantation from Living Adult Donors in the United States Robert S. Brown, Jr., M.D., M.P.H., Mark W. Russo, M.D., M.P.H., Michelle
More informationLiver transplantation is the only hope for patients with terminal. Indication and Prognosis of Liver Transplantation. Abstract
Indication and Prognosis of Liver Transplantation Jae Won Joh, M.D. Department of General Surgery Sungkyunkwan University School of Medicine Samsung Medical Center E mail: jwjoh@smc.samsung.co.kr Abstract
More informationWelcome to Transplantation
Renal Services Welcome to Transplantation Introductory guide to kidney transplantation. Welcome to Transplantation Kidney transplantation is not a cure for your renal disease it is just another form of
More informationEvaluation Process for Liver Transplant Candidates
Evaluation Process for Liver Transplant Candidates 2 Objectives Identify components of the liver transplant referral to evaluation Describe the role of the liver transplant coordinator Describe selection
More informationLiver Transplantation
Liver Transplantation Dr Mathew Jacob - MRCS FRCS CCT (UK) Lead Consultant HPB/Transplant Surgeon Aster Integrated Liver Care Program AsterMedcity, kochi, kerala, India mathew@transplantationliver.com
More informationInova Transplant Center
Inova Transplant Center I think I am a great candidate! Out with the old! in with the new! Help us help you! Pretransplant evaluation: goals Determine suitability as candidate Nature of surgery Optimize
More informationPRE-ASSESSMENT. Living Donor Liver Transplantation
No. 24 Oct 2003 Before decides to undertake a health technology assessment, a pre-assessment of the literature is performed. Pre-assessments are based on a limited literature search; they are not extensive,
More informationLiver Transplantation
1 Liver Transplantation Department of Surgery Yonsei University Wonju College of Medicine Kim Myoung Soo M.D. ysms91@wonju.yonsei.ac.kr http://gs.yonsei.ac.kr History Development of Liver transplantation
More informationWhat You Need to Know about a Kidney Transplant
Page 1 of 5 What You Need to Know about a Kidney Transplant This information will help you understand the risks, benefits and possible complications involved in a kidney transplant. Please read it carefully.
More informationSplit Graft Liver Transplant for Paediatric Patients in Hong Kong
HK J Paediatr (new series) 2009;14:181-185 Split Graft Liver Transplant for Paediatric Patients in Hong Kong PHY CHUNG, KKY WONG, PKH TAM, KL CHAN, KKC NG, SC CHAN, TWC HUI, BH YONG, ST FAN, CM LO Abstract
More informationExpanded Criteria Recipients: Are there any Limits
Expanded Criteria Recipients: Are there any Limits Andreas Paul, MD, MSc, FRCS Department of General-, Visceral- and Transplant Surgery, University Hospital Essen Ruhr Area 5.200 000 inhabitants University
More informationOntario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation
Ontario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation Version 2.0 Trillium Gift of Life Network Adult Pancreas-After-Kidney Transplantation Referral & Listing Criteria
More informationOntario s Adult Referral and Listing Criteria for Liver Transplantation
Ontario s Adult Referral and Listing Criteria for Liver Transplantation Version 3.0 Trillium Gift of Life Network Ontario s Adult Referral & Listing Criteria for Liver Transplantation PATIENT REFERRAL
More informationLiving Donor Liver Transplantation
Patient information Queen Elizabeth Hospital fl/igj Birmingham Part of University Hospitals Birmingham NHS Foundation Trust Birmingham Children's Hospital rliifj NHS Foundation Trust Living Donor Liver
More informationBariatric Surgery For Patients With End-Organ Failure
Bariatric Surgery For Patients With End-Organ Failure Arnold D. Salzberg, M.D. Andrew M. Posselt, M.D., PhD Divisions of Transplant and Minimally Invasive Surgery University of California, San Francisco
More informationChapter 4 Section 24.1
Surgery Chapter 4 Section 24.1 Issue Date: October 27, 1995 Authority: 32 CFR 199.4(e)(5) 1.0 CPT 1 PROCEDURE CODES 32850-32854, 33930-33935 2.0 DIAGNOSTIC RELATED GROUPS (DRGs) 495 for lung transplant.
More informationAdult-to-adult living donor liver transplantation Triumphs and challenges
Falk Symposium No. 163 on Chronic Inflammation of Liver and Gut Adult-to-adult living donor liver transplantation Triumphs and challenges ST Fan, MS, MD, PhD, DSc Professor Sun CY Chair of Hepatobiliary
More informationTypes of living donor transplants
TA L K I N G A B O U T T R A N S P L A N TAT I O N U N I T E D N E T W O R K F O R O R G A N S H A R I N G In response to the shortage of organs for transplantation, relatives, loved ones, friends, and
More informationGetting a New Kidney UHN. Information for patients and families. Is a kidney transplant right for me? Read this booklet to learn:
Getting a New Kidney UHN Information for patients and families Read this booklet to learn: about kidney transplants who can be donors how to start the transplant process how long the process might take
More informationLiver Transplantation Evaluation: Objectives
Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation
More informationLiving Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?
Original Article Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors? R. F. Saidi 1 *, Y. Li 2, S. A. Shah 2, N. Jabbour 2 1 Division of Organ Transplantation, Department
More informationCHAPTER 3 SECTION 1.6B HEART-LUNG AND LUNG TRANSPLANTATION TRICARE POLICY MANUAL M, MARCH 15, 2002 SURGERY AND RELATED SERVICES
TRICARE POLICY MANUAL 6010.47-M, MARCH 15, 2002 SURGERY AND RELATED SERVICES CHAPTER 3 SECTION 1.6B ISSUE DATE: October 27, 1995 AUTHORITY: 32 CFR 199.4(e)(5) I. CODES A. CPT 1 Procedure Codes 33930, 33935,
More informationTHE WORLD MEDICAL ASSOCIATION, INC. WMA STATEMENT ON ORGAN AND TISSUE DONATION
THE WORLD MEDICAL ASSOCIATION, INC. WMA STATEMENT ON ORGAN AND TISSUE DONATION Adopted by the 63rd WMA General Assembly, Bangkok, Thailand, October 2012 PREAMBLE Advances in medical sciences, especially
More informationOntario s Referral and Listing Criteria for Adult Heart Transplantation
Ontario s Referral and Listing Criteria for Adult Heart Transplantation Version 3.0 Trillium Gift of Life Network Adult Heart Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The
More informationCorporate Medical Policy Liver Transplant
Corporate Medical Policy Liver Transplant File Name: Origination: Last CAP Review: Next CAP Review: Last Review: liver_transplant 12/1995 5/2017 5/2018 5/2017 Description of Procedure or Service Liver
More informationPATIENT SELECTION FOR DECEASED DONOR KIDNEY ONLY TRANSPLANTATION
PATIENT SELECTION FOR DECEASED DONOR KIDNEY ONLY TRANSPLANTATION This policy has been created by the Kidney Advisory Group on behalf of NHSBT. The policy has been considered and approved by the Organ Donation
More informationUtility of Marginal Donors in Liver Transplantation
Utility of Marginal Donors in Liver Transplantation HwanHyo, Lee Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Contents Review of Liver Transplantation(LT)
More informationCandidates about. Lung Allocation Policy. for Transplant. Questions & A n s we r s TA L K I N G A B O U T T R A N S P L A N TAT I O N
TA L K I N G A B O U T T R A N S P L A N TAT I O N Questions & A n s we r s for Transplant Candidates about Lung Allocation Policy U N I T E D N E T W O R K F O R O R G A N S H A R I N G What are the OPTN
More informationWhat You Need to Know about a Heart Transplant
Page 1 of 8 What You Need to Know about a Heart Transplant This information will help you understand the risks, benefits, and possible complications involved in a heart transplant. Please read it carefully.
More informationControversies in Liver Transplantation
1183 CHAPTER 49 Controversies in Liver Transplantation James F. Trotter Division of Transplant Hepatology, Baylor University Medical Center, Dallas, TX, USA Key concepts The institution of liver allocation
More informationPatient Education Transplant Services. Glossary of Terms. For a kidney/pancreas transplant
Patient Education Glossary of Terms For a kidney/pancreas transplant Glossary of Terms Page 18-2 Antibody A protein substance made by the body s immune system in response to a foreign substance. Antibodies
More informationTransplant Hepatology
Transplant Hepatology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified
More informationEVALUATION & LISTING. Your Child s Liver Transplant Evaluation. What is the Liver?
EVALUATION & LISTING Your Child s Liver Transplant Evaluation The University of Michigan is a national leader in liver transplantation, as well as the surgical and medical management of patients with liver
More informationLIVER TRANSPLANTATION
Program and Surgical Director: Charles Miller, MD Medical Director: Nizar N. Zein, MD 216.444.8770 clevelandclinic.org/livertx Liver LIVER TRANSPLANTATION Cleveland Clinic performed 128 liver transplants
More informationStaging & Current treatment of HCC
Staging & Current treatment of HCC Dr.: Adel El Badrawy Badrawy; ; M.D. Staging & Current ttt of HCC Early stage HCC is typically silent. HCC is often advanced at first manifestation. The selective ttt
More informationLiving Donor Liver Transplantation
The Leeds Teaching Hospitals NHS Trust n Living Donor Liver Transplantation Information for patients This leaflet provides information to potential donors, families and recipients waiting for liver transplant
More informationNational Center for Child Health and Development Organ Transplantation Center
National Center for Child Health and Development Organ Transplantation Center A t the division of transplantation center in NCCHD, we have a mission to save children s life who have been suffered from
More informationFor more information about how to cite these materials visit
Author(s): Silas P. Norman, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/
More informationPOST TRANSPLANT OUTCOMES IN PSC
POST TRANSPLANT OUTCOMES IN PSC Kidist K. Yimam, MD Medical Director, Autoimmune Liver Disease Program Division of Hepatology and Liver Transplantation California Pacific Medical Center (CPMC) PSC Partners
More informationNHS. Living-donor lung transplantation for end-stage lung disease. National Institute for Health and Clinical Excellence. Issue date: May 2006
NHS National Institute for Health and Clinical Excellence Issue date: May 2006 Living-donor lung transplantation for end-stage Understanding NICE guidance information for people considering the procedure,
More informationAnne Barkman. The University of Kansas School of Nursing
Expanding Donor Criteria: Is it Safe? Anne Barkman The University of Kansas School of Nursing About the author: Anne Barkman is from Leawood, Kansas. She was an academic honor roll recipient for Fall 2010,
More informationMorbidity and Mortality After Living Kidney Donation, : Survey of United States Transplant Centers
American Journal of Transplantation 2003; 3: 830 834 Copyright # Blackwell Munksgaard 2003 Blackwell Munksgaard ISSN 1600-6135 Morbidity and Mortality After Living Kidney Donation, 1999 2001: Survey of
More informationUpdate in abdominal Surgery in cirrhotic patients
Update in abdominal Surgery in cirrhotic patients Safi Dokmak HBP department and liver transplantation Beaujon Hospital, Clichy, France Cairo, 5 April 2016 Cirrhosis Prevalence in France (1%)* Patients
More informationUniversity of Colorado Health Sciences Center, Denver Colorado ******************** ******************
University of Colorado Health Sciences Center, Denver Colorado ******************** 1988-2005 ****************** Disclosures No disclosures Case 53 M presents with sudden onset of upper abdominal pain
More informationPolicy Specific Section: May 16, 1984 April 9, 2014
Medical Policy Heart Transplant Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Transplant Original Policy Date: Effective Date: May 16, 1984 April 9, 2014 Definitions
More informationTA L K I N G A B O U T T R A N S P L A N TAT I O N
TA L K I N G A B O U T T R A N S P L A N TAT I O N Frequently Asked Questions about Kidney Transplant Evaluation and Listing If your kidneys have stopped working properly, or may stop working soon, you
More informationJohns Hopkins Hospital Comprehensive Transplant Center Informed Consent Form for Thoracic Organ Recipient Evaluation
Johns Hopkins Hospital Comprehensive Transplant Center Informed Consent Form for Thoracic Organ Recipient Evaluation The decision to undergo transplantation can be extremely difficult and often confusing.
More informationOverview Increasing organ donation (heart-beating donation Use of marginal grafts (quality) Cadaveric non-heart-beating donation Splitting Living dona
Increasing the organ supply Mr. Nigel Heaton Overview Increasing organ donation (heart-beating donation Use of marginal grafts (quality) Cadaveric non-heart-beating donation Splitting Living donation Domino
More informationTransplant in Pediatric Heart Failure
Transplant in Pediatric Heart Failure Francis Fynn-Thompson, MD Co-Director, Center for Airway Disorders Surgical Director, Pediatric Mechanical Support Program Surgical Director, Heart and Lung Transplantation
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
PAGE 1 of 6 PURPOSE To establish basic understanding of indications and contraindications for transplantation of various organs. POLICY The N.C. Department of Correction, Division of Prisons, Health Services
More informationFinal Report: Update on Prior Living Donors Who Were Subsequently Placed on the Waiting List
OPTN/UNOS Minority Affairs Committee Descriptive Data Request Final Report: Update on Prior Living Donors Who Were Subsequently Placed on the Waiting List Prepared for: Minority Affairs Committee Meeting
More informationWestern Health Specialist Clinics Access & Referral Guidelines
Gastroenterology Specialist Clinics at Western Health: Western Health provides the following Specialist Clinics for patients who require assessment and management of Gastroenterology / Hepatology conditions.
More informationExperience with Liver Transplantation in patients over 65 years of Age at the Hospital Pablo Tobón Uribe in Medellin, Colombia from 2004 to 2010
Original articles Experience with Liver Transplantation in patients over 65 years of Age at the Hospital Pablo Tobón Uribe in Medellin, Colombia from 2004 to 2010 Octavio Muñoz, MD, 1 Laura Ovadía, MD,
More informationOutcome Analysis in Adult-to-Adult Living Donor Liver Transplantation Using the Left Lobe. Patients
Outcome Analysis in Adult-to-Adult Living Donor Liver Transplantation Using the Left Lobe Yuji Soejima, Mitsuo Shimada, Taketoshi Suehiro, Shoji Hiroshige, Mizuki Ninomiya, Satoko Shiotani, Noboru Harada,
More informationTumor incidence varies significantly, depending on geographical location.
Hepatocellular carcinoma is the 5 th most common malignancy worldwide with male-to-female ratio 5:1 in Asia 2:1 in the United States Tumor incidence varies significantly, depending on geographical location.
More informationThanks to our Speakers!
Thanks to our Speakers! Fizza Naqvi, MD Assistant Professor at the Department of Medicine (Nephrology), Johns Hopkins Attending physician at Johns Hopkins hospital. Involved with kidney recipient evaluation
More informationPaediatric Liver Transplant Programme Wits Donald Gordon Medical Centre
Paediatric Liver Transplant Programme Wits Donald Gordon Medical Centre J Loveland, J Botha, R Britz, B Strobele, S Rambarran, A Terblanche, C Kock, P Walabh, M Beretta, M Duncan et al 1817 reveal the
More informationSeptember 28, 2013 Jennifer Butler, RN, CCTC
How To Get Listed for Kidney Transplant September 28, 2013 Jennifer Butler, RN, CCTC Objectives What kidney failure is 3 major forms of treatment Kidney transplant evaluation Kidney transplant List Functions
More informationLIVER TRANSPLANTATION
Imtiaz Alam, M.D. Phone: [512] 719-4370 Mandy Mishra, CNS Fax: [512] 719-4371 Austin Hepatitis Center 12201, Renfert Way Suite 235 Austin, TX 78758 LIVER TRANSPLANTATION The liver is the largest and one
More informationCurrent status of hepatic surgery in Korea
Korean J Hepatol. 2009 Dec; 15(Suppl 6):S60 - S64. DOI: 10.3350/kjhep.2009.15.S6.S60 Current status of hepatic surgery in Korea Kyung Sik Kim Department of Surgery, Severance Hospital, Yonsei University
More informationChapter 4 Section Combined Heart-Kidney Transplantation (CHKT)
Surgery Chapter 4 Section 24.3 Issue Date: May 7, 1999 Authority: 32 CFR 199.4(e)(5) 1.0 POLICY 1.1 is a TRICARE benefit that requires preauthorization. 1.1.1 A TRICARE Prime enrollee must have a referral
More informationThe NJ Sharing Network Organ and Tissue Donation as an End of Life option for Families
The NJ Sharing Network Organ and Tissue Donation as an End of Life option for Families NJ Sharing Network Private non-profit service organization Federal designation to provide recovery services State
More informationLiver and intestine transplantation: summary analysis,
American Journal of Transplantation 25; 5 (Part 2): 916 933 Blackwell Munksgaard Blackwell Munksgaard 25 Liver and intestine transplantation: summary analysis, 1994 23 Douglas W. Hanto a,, Thomas M. Fishbein
More informationWhat Is the Real Gain After Liver Transplantation?
LIVER TRANSPLANTATION 15:S1-S5, 9 AASLD/ILTS SYLLABUS What Is the Real Gain After Liver Transplantation? James Neuberger Organ Donation and Transplantation, NHS Blood and Transplant, Bristol, United Kingdom;
More information4/26/2017. Liver Transplant and Palliative Care: Teaming up to improve care
Liver Transplant and Palliative Care: Teaming up to improve care Jody C. Olson, M.D., FACP Assistant Professor of Medicine and Surgery Hepatology and Critical Care Medicine All patients with end-stage
More informationMedical Writers Circle October 2008
The HCV Advocate www.hcvadvocate.org Medical Writers Circle October 2008 a series of articles written by medical professionals about the management and treatment of hepatitis C Lorenzo Rossaro, M.D., F.A.C.P.,
More informationMODERATOR Felix Rapaport, other members of this
The First Lung Transplant in Man (1963) and the First Heart Transplant in Man (1964) J.D. Hardy MODERATOR Felix Rapaport, other members of this distinguished panel, and members of the audience, I will
More informationLong Term Follow-up. 6 Month 1 Year Annual enter year #: What is the assessment date: / / Unknown. Is the patient alive? Yes No
Long Term Follow-up 6 Month 1 Year Annual enter year #: What is the assessment date: / / Unknown Is the patient alive? Yes No Was an exam performed by a bariatric physician or PA/NP? Yes No Was the patient
More informationUW MEDICINE REGIONAL HEART CENTER HEART TRANSPLANT. Orientation Class at University of Washington Medical Center
UW MEDICINE REGIONAL HEART CENTER HEART TRANSPLANT Orientation Class at University of Washington Medical Center OVERVIEW This slideshow explains: Your Transplant Evaluation Transplant Listing Heart Transplant
More informationSTANDARDS FOR HEPATO-PANCREATO-BILIARY TRAINING. Education and Training Committee INTERNATIONAL HEPATO-PANCREATO-BILIARY ASSOCIATION 2008
STANDARDS FOR HEPATO-PANCREATO-BILIARY TRAINING Education and Training Committee INTERNATIONAL HEPATO-PANCREATO-BILIARY ASSOCIATION 2008 1.0 DEFINITIONS 1.1 Hepato-Pancreato-Biliary (HPB) Surgeon 1.2 Hepato-Pancreato-Biliary
More informationGlossary. Anesthesiologist A doctor who puts you or parts of your body to sleep during surgery.
1-Glossary Glossary Acute rejection A type of rejection that occurs when immune cells from your body attack the transplanted organ(s). Acute rejection may occur at any time after a transplant. But it usually
More informationTREATMENT FOR HCC AND CHOLANGIOCARCINOMA. Shawn Pelletier, MD
TREATMENT FOR HCC AND CHOLANGIOCARCINOMA Shawn Pelletier, MD Treatment for HCC Treatment strategies Curative first line therapy Thermal ablation vs Resection vs Transplant Other first line therapies TACE
More informationHepatocellular Carcinoma: Diagnosis and Management
Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm
More informationUnderstanding Liver Disease
Visit us on the Web at: clevelandclinic.org/liver To make an appointment call: 888.410.1775, option 1 International patients call: 001.216.444.8184 WOULD YOU LIKE A SECOND OPINION? If you would like a
More informationInterventional Radiology in Liver Cancer. Nakarin Inmutto MD
Interventional Radiology in Liver Cancer Nakarin Inmutto MD Liver cancer Primary liver cancer Hepatocellular carcinoma Cholangiocarcinoma Metastasis Interventional Radiologist Diagnosis Imaging US / CT
More informationJaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD
Jaundice Agnieszka Dobrowolska- Zachwieja, MD, PhD Jaundice definition Jaundice, as in the French jaune, refers to the yellow discoloration of the skin. It arises from the abnormal accumulation of bilirubin
More informationPredictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
Pediatr Transplantation 2013: 17: 436 440 2013 John Wiley & Sons A/S. Pediatric Transplantation DOI: 10.1111/petr.12095 Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
More informationCorporate Medical Policy Liver Transplant and Combined Liver-Kidney Transplant
Corporate Medical Policy Liver Transplant and Combined Liver-Kidney Transplant File Name: Origination: Last CAP Review: Next CAP Review: Last Review: liver_transplant_and_combined_liver_kidney_transplant
More informationPatient Name: MRN: DOB: Treatment Location:
Page 1 of 5 I. TO (Required) This Section is required to be completed by all patients who undergo kidney transplant surgery. I hereby consent to and authorize Dr. and his/her assistant(s), including supervised
More informationObjectives 9/23/2014. Why is Organ Donation Important? Conflict of interest-none
Objectives Understand the role of the UW OTD Discuss the need for organ donation From referral to recovery: An overview of the phases of the organ donation process Discuss the importance of the provider
More informationCovered Critical Illness Conditions Appendix
Covered Critical Illness Conditions Appendix Effective Date: February 1, 2010 This Appendix contains definitions for those Conditions that are covered under the Manulife Financial Group Critical Illness
More informationPatient Acknowledgement for Kidney, Pancreas or Kidney-Pancreas Transplant
Patient Acknowledgement for Kidney, Pancreas or Kidney-Pancreas Transplant This form provides information about having a kidney transplant. It describes the purpose, process, tests, risks, benefits, and
More informationCurrent State of Living Donor Liver Transplantation
REVIEW Current State of Living Donor Liver Transplantation Paige M. Porret, Kim M. Olthoff The discrepancy between the number of patients waiting for a liver and the available number of deceased donors
More informationThe transplant benefit score and the national liver offering scheme
The transplant benefit score and the national liver offering scheme New national offering scheme The development of a national set of rules to offer livers to named adult patients on the elective liver
More informationOntario s Paediatric Referral and Listing Criteria for Small Bowel and Liver- Small Bowel Transplantation
Ontario s Paediatric Referral and Listing Criteria for Small Bowel and Liver- Small Bowel Transplantation Version 3.0 Trillium Gift of Life Network Ontario s Paediatric Referral and Listing Criteria for
More informationCertified Clinical Transplant Nurse (CCTN) * Detailed Content Outline
I. PRETRANSPLANTATION CARE 9 11 3 23 A. Evaluate End-Stage Organ Failure 1 1 1 3 1. History and physical assessment 2. Vital signs and / or hemodynamic parameters 3. Lab values 4. Diagnostic tests B. Monitor
More information